PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q3 2021 PAVmed Inc Earnings Call Transcript

Nov 16, 2021 / 09:30PM GMT
Release Date Price: €52.78 (+0.48%)
Operator

Hello and welcome to the PAVmed and Lucid Diagnostics Joint Business Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to turn the call over to Lisa DeScenza, Vice President of Integrated Communications at the LaVoieHealthScience. Please go ahead, Lisa.

Lisa V. DeScenza
LaVoie Strategic Communications Group, Inc. - Head of Marketing & Business Development and VP of Integrated Communications

Thank you, operator. Good afternoon, everyone. This is Lisa DeScenza, supporting PAVmed and Lucid's Investor Relations. Thank you for participating in today's business update call.

Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer PAVmed and Chairman and Chief Executive Officer of Lucid Diagnostics, along with Dennis McGrath, President and Chief Financial Officer of PAVmed and Chief Financial Officer of Lucid Diagnostics.

The press release announcing our business updates and financial results is available on PAVmed and Lucid's websites

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot